Home > PJ (current issue) > News Feature | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7479 p581
24 November 2007

This article
Reprint   Photocopy

PDF 40K, Acrobat Reader

News feature

D-day for pharmacy, says Dr Ridge

The Health and Social Care Bill, which sets the framework for creating the General Pharmaceutical Council has had its First Reading in Parliament. Mike Thompson (on the staff of The Journal) reports on how the Department of Health intends to proceed

Related websites
Separating professional regulation and representation


Timer set to establish the General Pharmaceutical Council

Timer set to establish the GPhC

Timetable

The planned timetable for the creation of the GPhC and the transfer of regulatory functions:

November 2007
Health and Social Care Bill published

May 2008
Consultation on new S60 Order

Second half 2008
Royal Assent for Health and Social Care Bill

April 2009
S60 Order made

July 2009
Shadow GPhC created

January 2010
GPhC fully operational

Moves towards stripping the Royal Pharmaceutical Society of its regulatory functions and vesting them in a new General Pharmaceutical Council began in earnest on 15 November 2007, with the First Reading in Parliament of the Health and Social Care Bill.

“This is D-day for pharmacy,” Keith Ridge, chief pharmaceutical officer at the Department of Health, said this week. “The Bill contains power to remove all regulatory powers from the Royal Pharmaceutical Society and transfer them to a new regulator, the GPhC.

“After years of debate and speculation, after the White Paper ‘Health, assurance and safety’, we are where we are. We have no choice. We have to be like the other health professions.

“The Society will be split and it is up to us to make sure it happens professionally, safely and effectively.”

The Bill itself makes no reference whatsoever to the planned creation of the GPhC.

Instead, it seeks to amend Section 60 of the Health Act 1999, under which a series of Orders in Council (secondary legislation) have already been used to alter the regulatory machinery of many health professions.

The proposed amendment will allow S60 Orders to be used to amend the following regulatory systems:

• Registration of pharmacy premises

• Regulation of retail pharmacy businesses

• Enforcement of the Medicines Act

• Enforcement of relevant provision of the Poisons Act 1972 and the Poisons (Northern Ireland) Order 1976

• Authorisation of surveillance by the pharmacy regulator

Jeannette Howe, head of pharmacy at the DoH, said: “We need to be able to transfer functions of the Society in relation to premises and businesses, as well as to individuals.”

The proposed amendment also explicitly states that a S60 Order may not be used to abolish the Royal Pharmaceutical Society, the Pharmaceutical Society of Northern Ireland or the GPhC once it has been established.

The planned S60 Orders will be used to:

• Establish the GPhC

• Transfer all the Society’s statutory functions to the GPhC

• Transfer statutory functions of the PSNI to the GPhC if the ministers for Northern Ireland decide to follow that course

Ms Howe said that the S60 Order approach had already been used successfully to update the regulation of pharmacists by the Society and had the advantage of being able to keep pace with the changing needs of the professions without the sort of delay that occurred with primary legislation because of constraints on Parliamentary time.

Dr Ridge confirmed that the profession should expect more than one S60 Order before the reform of pharmacy regulation is complete. “The first S60 Order will include essential things,” he said. “The S60 process means that we can tackle the project at large in several pieces,” he said. One of these pieces will be the introduction of mandatory continuing professional development.

“The DoH is currently drawing up a detailed critique of the [Pharmacists and Pharmacy Technicians Order 2007],” Dr Ridge said. “It is likely to delay regulation on some outstanding parts, such as [mandatory] CPD and rules around education.”

He added that the aim will be to bring in CPD at the same time as the GPhC, but to target it at certain sections of the profession. “Pharmacist prescribers are likely to be the first target,” he stated.

Dr Ridge said that the Pharmacy Regulation and Leadership Oversight Group (PRLOG), which is working with ministers to establish the GPhC and to oversee the formation of a professional leadership body, had met twice and would continue to meet four times a year.

He emphasised that this was an oversight group with no executive role (PJ, 21 July, p61). It has two work streams. One, on establishing the GPhC, is led by Dr Ridge, while the other, on regulatory support, is headed by Peter Noyce, professor of pharmacy practice at Manchester University.

“PRLOG will not be successful if it works in isolation,” Dr Ridge said. “It will need the support of the profession.” To this end, a website will be created so that people can follow progress which they will be able to use to send their thoughts to the group.

The PRLOG’s terms of reference

Other provisions of the Health and Social Care Bill

The Health and Social Care Bill contains a number of other provisions of relevance to pharmacy.

It will enable the creation of an Office of the Health Professions Adjudicator to take over the adjudication of fitness-to-practise cases involving doctors and opticians. Ms Howe said that the OHPA would be able take over the adjudication of cases involving other professions only with the agreement of the regulator involved.

There will also be a new Care Quality Commission to take over the functions of the Commission for Healthcare Audit and Inspection, the Commission for Social Care Inspection and the Mental Health Act Commission.

All providers of health services and adult social care, including NHS providers, will be required to register with the CQC. In the case of community pharmacies, registration is expected to be required only in respect of any specialised services they provide that are beyond the normal remit of professional pharmacy services.

This is expected to apply to services that were previously carried out by hospitals and which have been transferred to community-based providers.

The Bill is also being used as the means by which responsibility for the NHS remuneration of community pharmacies (the global sum) will be transferred to primary care trusts in England and local health boards in Wales.

Back to Top


©The Pharmaceutical Journal